Why are normal lab ranges not designed with fertility in mind?
Normal lab reference ranges were developed to identify clinical disease, not to optimize reproductive outcomes. The populations used to establish these ranges were not selected for fertility, and the threshold for abnormal was set at the point where symptoms, dysfunction, or disease risk become clinically significant in the general population.
The standard diagnostic framework asks one question: is this result outside the range seen in a broadly healthy general population? A result outside that range triggers clinical attention. A result inside that range gets marked normal, regardless of whether it sits near the lower boundary, the upper boundary, or the midpoint.
Fertility optimization requires different precision. Conception and early pregnancy depend on a hormonal environment calibrated within narrow windows. A TSH of 4.5 and a TSH of 1.2 are both normal by standard reference ranges. From a fertility perspective, TSH at 4.5 is associated with reduced implantation rates and elevated miscarriage risk, while TSH at 1.2 is in the zone most consistently associated with healthy conception outcomes.
Research published in the journal Thyroid found that women with TSH levels above 2.5 mIU/L had meaningfully higher rates of first-trimester loss than women with TSH below 2.5, even though both groups had results within the standard normal range.
Which specific fertility markers have a meaningful gap between normal and optimal?
The fertility markers with the most clinically significant gap between normal and optimal include TSH, vitamin D, mid-luteal progesterone, and fasting insulin. Each has a standard reference range accepted in general medical practice and a narrower fertility-relevant target that most standard workups do not apply.
Key markers and their respective targets:
- TSH: Standard normal 0.5 to 5.0 mIU/L. Fertility-optimal target: 1.0 to 2.5 mIU/L.
- Vitamin D: Standard normal above 20 ng/mL. Fertility-relevant target: 50 to 80 ng/mL.
- Mid-luteal progesterone: Standard normal above 10 ng/mL. Fertility-optimal target: above 20 ng/mL for implantation support.
- Fasting insulin: Standard normal below 25 mIU/L. Metabolic-optimal target for fertility: below 10 mIU/L.
For AMH, the distinction is more nuanced. An AMH described as low-normal may be appropriate for a 40-year-old and warrant closer attention in a 32-year-old. The number must be read in clinical context, not against a single threshold.
According to the Society for Endocrinology, subclinical hypothyroidism (TSH above 4.0 mIU/L with normal T4) affects an estimated 3 to 8 percent of reproductive-age women and is consistently associated with reduced fertility and higher miscarriage risk, despite falling within the standard normal range.
How do I find out where my result falls within the normal range?
Ask your doctor or lab for your actual numeric value, not just a normal or abnormal flag. The number itself, read alongside the reference range and the fertility-optimal target, tells you far more than the designation alone.
Most lab reports include the reference range alongside the result. A result reported as “TSH: 3.8 (reference: 0.5 to 5.0)” tells you the result is normal but positioned in the upper third of that range. Knowing that the fertility-optimal target for TSH is 1.0 to 2.5 tells you the result is technically normal but not in the zone most associated with conception.
Steps to evaluate your results:
- Request a printed or digital copy of your full lab results, including the reference range for each marker
- Note where your result sits within the range, not just whether it is normal
- Compare each result to fertility-optimal targets, which your general practitioner may not be applying
- Bring the results to a reproductive endocrinologist or integrative reproductive specialist who interprets values in a fertility context
A review in Human Reproduction found that most women reporting an unexplained infertility diagnosis had never been shown their actual numeric results, only whether each marker was within the normal range.
What happens when a result is normal but not optimal for fertility?
When a result is normal but not in the fertility-optimal zone, the physiological environment for conception may be compromised in ways that do not show up as clinical dysfunction. The body can function adequately at the edges of the normal range while still falling short of the hormonal precision that conception and early pregnancy require.
The clearest example is thyroid function. A woman with a TSH of 4.2 has a normal result by standard criteria. But at TSH 4.2, research consistently links elevated thyroid-stimulating hormone within the normal range to reduced egg quality, lower implantation rates, and higher rates of early pregnancy loss, even in the absence of diagnosed hypothyroidism.
Vitamin D illustrates the same pattern. A level of 22 ng/mL is technically sufficient by general health standards. Vitamin D receptor activity in ovarian function, endometrial receptivity, and immune regulation during implantation is most consistently supported at levels above 40 to 50 ng/mL.
A 2022 meta-analysis published in Nutrients found that vitamin D sufficiency was significantly associated with improved IVF outcomes, including higher rates of clinical pregnancy and live birth, compared to vitamin D insufficiency even within the standard normal range.
Should I ask my doctor to interpret my results against fertility-optimal ranges?
Yes. Asking your doctor to interpret your results against fertility-optimal targets, rather than standard reference ranges, is a reasonable and well-supported request. Reproductive endocrinologists and most integrative practitioners are familiar with fertility-specific targets. General practitioners and OBGYNs may be less so, which is worth knowing before the conversation.
How to frame the conversation:
- “Where does my result fall within the reference range, not just whether it is normal?”
- “Are you interpreting these values against general population ranges or fertility-specific targets?”
- For TSH: “Some reproductive specialists target TSH between 1.0 and 2.5 for women trying to conceive. Does my result fall within that zone?”
If your doctor is unfamiliar with fertility-optimal targets or dismisses the question, that is useful information about whether the current clinical setting is equipped to support a root-cause fertility investigation. A second opinion from a reproductive endocrinologist or an integrative reproductive medicine practitioner is entirely appropriate.
The American Thyroid Association’s 2017 guidelines on thyroid disease in pregnancy recommend maintaining TSH below 2.5 mIU/L in women trying to conceive, a target that differs from general population reference ranges and supports the clinical validity of asking this question.
The The Fertility Intelligence Hub Perspective
The number matters more than the label
One thing I find myself saying often in a first conversation: the number matters more than the label.
When someone shows me labs and says everything came back normal, I ask to see the actual values. Most of the time, the results that are normal by standard criteria are not in the zone I would consider optimal for fertility. The difference is not small, and it is not rare.
This is not a criticism of medicine. It is a structural gap. Standard reference ranges were built to catch disease. They were not built to support the precise hormonal environment that conception requires. Those are two different problems, and they need two different lenses.
The work I do with clients begins with reading results differently. Not asking “is this flagged?” but “where does this sit relative to what we know supports fertility?” That reframe often reveals three or four markers that are technically fine and functionally worth addressing.
Fertility Block Mapping is partly a diagnostic reframe: looking at existing results through a different lens before ordering anything new. Most of the time, there is more information in the labs already collected than anyone has taken the time to interpret correctly.
